Corona treatment

Groundbreaking COVID-19 Air Disinfection Is Here as APJeT Achieves Complete ‘Kill’ of Surrogate Human Coronavirus With Its Patent Pending Air Plasma Technology

Retrieved on: 
Tuesday, January 12, 2021
Health, Infectious diseases, Other Science, Construction & Property, Building Systems, Science, Plasma physics, Electromagnetism, Materials, Physical sciences, Gases, Hygiene, Astrophysics, Plasma, Corona discharge, Disinfectant, Corona treatment

The Company will introduce its new-tech air plasma disinfection systems to the market this quarter.

Key Points: 
  • The Company will introduce its new-tech air plasma disinfection systems to the market this quarter.
  • Independent testing at ResInnova Laboratories , proved APJeTs plasma surface disinfection "wand" to achieve a complete "kill" on a human coronavirus (a COVID-19 surrogate) when applied for only 90 seconds.
  • APJeTs plasma air disinfection device, the COVIDINATOR, was tested and certified results confirm a complete elimination, or "total kill", in one pass of room-circulated air.
  • APJeTs plasma disinfection systems use a patent-pending cold plasma technology that breakdown the oxygen (O2) and nitrogen (N2) molecules in air into individual atoms.

airPHX Announces Groundbreaking Advance in Plasma Technology

Retrieved on: 
Wednesday, November 7, 2018
Physics, Astrophysics, Gases, Plasma, Nature, Plasma physics, Plasma processing, Corona treatment

10,111,977 covering significant advances to cold plasma technology developed and owned by PhoenixAIRE, LLC d/b/a airPHX.

Key Points: 
  • 10,111,977 covering significant advances to cold plasma technology developed and owned by PhoenixAIRE, LLC d/b/a airPHX.
  • The Company has successfully commercialized its current generation of cold plasma technology and is actively deploying the technology across various industries including food safety, health care, athletics and others.
  • The issued patent covers a new method of generating cold plasma, creating a plasma "curtain" and opening new markets and applications for this innovative technology.
  • This patent adds to the Company's IP portfolio and confirms airPHX as the global leader in commercial applications of cold plasma technology.